Skip to content

Examination of continuous ingestion of drink containing plant extract. N-18003

Examination of continuous ingestion of drink containing plant extract. N-18003 - Examination of continuous ingestion of drink containing plant extract. N-18003

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031587
Enrollment
12
Registered
2018-03-09
Start date
2018-03-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Continuous ingestion of drink containing plant extract Continuous ingestion of placebo drink not containing plant extract

Sponsors

Japanese Red Cross Hokkaido College of Nursing
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Healthy adults 2.Person who agrees not to ingest specified foods and supplements during the test period.

Exclusion criteria

Exclusion criteria: 1.Person whose diastolic blood pressures are more than 90mmHg and systolic ones are more than 140mmHg. 2.Person who has severe allergic disease as rhinitis, atopicdermatitis. 3.Person who is pregnant, lactating or planned to become pregnant during the test period. 4.Patient with vascular function disorder. 5.Person who has problems with electrocardiogram test such as arrhythmia. 6.Person who takes medicine. 7.Person who regularly goes to hospital or went to the medical institution within a month. 8.Current smoker. 9.Person who plans to participate in the other clinical studies. 10.Person who is judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Skin temperature.

Secondary

MeasureTime frame
Peripheral blood flow, subjective evaluation and autonomic nerve activity.

Countries

Japan

Contacts

Public ContactYukinori Nakashima

Kao Corporation R&D-Skin Care Products Research

nakashima.yukinori@kao.com+81-3-5630-9581

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026